Janssen Search
Search results
Janssen Immunology R&D – ACG 2020 Newsroom
Welcome to the Janssen Immunology ACG 2020 Newsroom! Please see below for the latest meeting news, a message from our leaders, social feeds, and more information about our progress and commitment to developing innovative medicines for Inflammatory Bowel ...
Progress in the Journey to Transform the Treatment of Bladder Cancer
Progress in the Journey to Transform the Treatment of Bladder Cancer Today at the 2023 American Urological Association (AUA) annual meeting, Janssen presented the first results from a comprehensive clinical program evaluating an investigational drug ...
Recognizing Lung Cancer Awareness Month 2019
Recognizing Lung Cancer Awareness Month 2019 Lung cancer is a devastating disease with an annual mortality rate higher than breast, colon and prostate cancer combined. This alarming statistic, and the loss of my own grandfather to lung cancer several ...
Commercialization: A Common Vision in Oncology
Commercialization: Strategically Aligned to Achieve a Common Vision in Oncology Innovation “A good drug doesn’t sell itself. Our commercial organization is the link between research and development and the marketplace – we work to incorporate physician, ...
Contact Infectious Diseases & Vaccines
Article Type: Infectious Diseases & Vaccines Contact Infectious Diseases & Vaccines Thank you for your interest in learning more about us. What are you interested in? Collaborations Research & Development Media Inquiries Therapeutic Area or ...
Monique Adams, Ph.D.
Monique Adams, Ph.D. DIRECTOR, JCI Monique Adams is the Director of Janssen Clinical Innovation, where she leads the strategy development and implementation plans for innovation initiatives within patient centrality, non-conventional trial methods, and ...
Partner with the Janssen Human Microbiome Institute
Article Type: Disease Interception Accelerator Partner with the Janssen Human Microbiome Institute The Janssen Human Microbiome Institute (JHMI), part of Janssen Research & Development, LLC is focused on understanding the unique and crucial role that ...
Tom Mickelson
TOM MICKELSON Vice President Global Therapeutic Area Leader Dermatology & Rheumatology Tom Mickelson is Vice President, Dermatology & Rheumatology Global Therapeutic Area Leader at Janssen Research & Development, LLC. In this role, he leads ...
Lisa Shea
Lisa Shea Scientific Patient Engagement Leader Janssen Scientific Affairs Lisa Shea is the Scientific Patient Engagement Leader for Janssen Scientific Affairs. Lisa is responsible for bringing the patient perspective in-house and leveraging it to drive ...
Equitable Access: How Janssen is Re-Imagining the Future of Clinical Trials
Equitable Access: How Janssen is Re-Imagining the Future of Clinical Trials What does “innovation” mean to you? We hear it so often in today’s world; it appears as though everyone is innovating. In fact, it would almost seem odd if a core pillar of a ...